Log In
Print this Print this

centanafadine SR (EB-1020 SR)

  Manage Alerts
Collapse Summary General Information
Company Neurovance Inc.
DescriptionSustained-release formulation of a serotonin, norepinephrine and dopamine reuptake inhibitor that preferentially targets norepinephrine and dopamine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat adult ADHD
Regulatory Designation
PartnerEuthymics Bioscience Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today